Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions

被引:0
作者
Isabelle Matte
Clara Major Legault
Perrine Garde-Granger
Claude Laplante
Paul Bessette
Claudine Rancourt
Alain Piché
机构
[1] Université de Sherbrooke,Département de Microbiologie et Infectiologie
[2] Université de Sherbrooke,Département de Pathologie
[3] Université de Sherbrooke,Département de Chirurgie, Service d’Obstétrique
来源
Clinical & Experimental Metastasis | 2016年 / 33卷
关键词
3D culture; Ovarian cancer; Spheroids; Mesothelial cells;
D O I
暂无
中图分类号
学科分类号
摘要
Epithelial ovarian cancer (EOC) dissemination is primarily mediated by the shedding of tumor cells from the primary site into ascites where they form multicellular spheroids that rapidly lead to peritoneal carcinomatosis. While the clinical importance and fundamental role of multicellular spheroids in EOC is increasingly appreciated, the mechanisms that regulate their formation and dictate their cellular composition remain poorly characterized. To investigate these important questions, we characterized spheroids isolated from ascites of women with EOC. We found that in these spheroids, a core of mesothelial cells was encased in a shell of tumor cells. Analysis further revealed that EOC spheroids are dynamic structures of proliferating, non-proliferating and hypoxic regions. To recapitulate these in vivo findings, we developed a three-dimensional co-culture model of primary EOC and mesothelial cells. Our analysis indicated that, compared to the OVCAR3 cell line, primary EOC cells isolated from ascites as well as mesothelial cells formed compact spheroids. Analysis of heterotypic spheroid microarchitecture revealed a structure that grossly resembles the structure of spheroids isolated from ascites. Cells that formed compact spheroids had elevated expression of β1 integrin and low expression of E-cadherin. Addition of β1 integrin blocking antibody or siRNA-mediated downregulation of β1 integrin resulted in reduced tightness of the spheroids. Interestingly, the loss of MUC16 and E-cadherin expression resulted in the formation of more compact spheroids. Therefore, our findings support the heterotypic nature of spheroids from malignant EOC ascites. In addition, our data describe an unusual link between E-cadherin expression and less compact spheroids. Our data also emphasize the role of MUC16 and β1 integrin in EOC spheroid formation.
引用
收藏
页码:839 / 852
页数:13
相关论文
共 284 条
[11]  
Bookman MA(2013)Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment PLoS One 8 e57056-2308
[12]  
Connolly DC(2010)Kallikrein-related peptidase 7 promotes multicellular aggregation via the α5β1 integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma Cancer Res 70 2624-282
[13]  
Daly MB(1999)Taxol-induced bcl-2 phosphorylation in ovarian cancer monolayer and spheroids Int J Oncol 14 515-298
[14]  
Godwin AK(2015)B-catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids Oncogene 34 2297-413
[15]  
Schilder RJ(2013)Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research Nat Rev Cancer 13 273-443
[16]  
Xu X(2014)Role of malignant ascites on human mesothelial cells and their gene expression profiles BMC Cancer 14 288-2649
[17]  
Hamilton TC(2015)Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms Int J Cancer 137 289-885
[18]  
Shield K(2012)Three-dimensional cell culture models for biomarker discoveries and cancer research Transl Med S1 005-181
[19]  
Ackland ML(2012)Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis J Ovar Res 5 34-999
[20]  
Ahmed N(2009)CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis Gynecol Oncol 115 407-205